HealthTech expert and innovator Garry McCord has joined HBSUK as its new CEO to lead the group through its next exciting growth phase. HBSUK is a leading provider of clinical insourcing services to the NHS. The group was established in 2012 by accomplished healthcare professional and entrepreneur, Mark Fountain, who now moves to Executive Chair.…
Leading Orthopaedics Business, MatOrtho, has appointed Duncan Wilson as CEO. Duncan Wilson has been appointed the new CEO of MatOrtho, a leading designer and manufacturer of orthopaedic implant devices. Duncan brings with him strong leadership experience and a background predominantly in medical devices, where he has scaled and led European businesses to successfully commercialise specialty…
Leading Specialty Pharmaceuticals Business, Kent Pharma, has appointed Terry Petersen as CEO Terry Petersen has been appointed the new CEO of Kent Pharma, a leading manufacturer and distributor of specialty pharmaceuticals. Terry brings with him strong leadership experience and a background predominantly in pharmaceuticals, where he has positively designed, started, scaled and led European businesses…
Private equity-backed Marsden Group has appointed Indy Purewal as CFO. Indy joins private equity-backed Marsden from manufacturing group, Esterform, where he served as Group Finance Director. With a strong entrepreneurial background, experience with acquisitions, sale processes and operating at a board level, Indy’s move to Marsden adds to its strong leadership team. Marsden has a…
Carter Schwartz’s Head of Practice, Private Equity, Lewis Buckley recently advised on two key appointments for international medical devices company, Biocomposites. Simon Greenhalgh is the new Group Chief Financial Officer, and Peter Webster takes up the position as UK General Manager. Simon has extensive private equity experience having led on M&A investment and integration activities as Group CFO…
During the latter part of 2021 and Q1 of 2022, Carter Schwartz successfully advised on growth-focused team builds for our Healthcare, Social Care and Life Science clients. Orthopaedic implants company MatOrtho and their investor Connection Capital worked with us on their recent key hires and this is what they had to say…READ MORE But don’t…
Leatherhead-based orthopedic company MatOrtho has made two new commercial appointments. Tim Lawes has joined the business as Vice President of Global Marketing, with David Clapcott joining as Vice President of Global Sales following investment by Connection Capital LLP. In his role, Tim will be responsible for devising and implementing commercial strategies to drive further uptake…
Chiltern Capital has invested in Surepharm, a contract development manufacturing organisation servicing the pharmaceutical market. Carter Schwartz’s, Lewis Buckley, advised on the management team hires. Surepharm provides outsourced formulation, development, manufacturing, and packaging of products for its customers in the UK and overseas. It currently specialises in producing solid dose tablets and capsules, including niche…
Leatherhead-based medical devices company MatOrtho has appointed Simon Cartmell as a non-executive director, following a recent investment by private equity firm, Connection Capital. Cartmell will support the management team as MatOrtho aims for international growth and development pathways in the wake of this recent investment. Cartmell has over 35 years of leadership experience in the…
